We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+43.02%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$73.4M
AUM Growth
+$10.7M
Cap. Flow
-$10.8M
Cap. Flow %
-14.75%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$739K
2
ME
23andMe Holding Co
ME
+$201K

Top Sells

Rank Stock Value
1
ACRS icon
Aclaris Therapeutics
ACRS
+$8.62M
2
CMPX icon
Compass Therapeutics
CMPX
+$2.46M
3
PHVS icon
Pharvaris
PHVS
+$692K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
1
Hims & Hers Health
HIMS
$6.5B
$34.1M 46.49%
3,833,381
+100,000
+3% +$739K
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$16.6M 22.67%
4,108,796
– –
IRON icon
3
Disc Medicine
IRON
$2.83B
$14.1M 19.16%
243,513
– –
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$8.36M 11.39%
3,525,957
– –
ME
5
DELISTED
23andMe Holding Co
ME
$212K 0.29%
+11,610
New +$201K
ACRS icon
6
Aclaris Therapeutics
ACRS
$730M
– –
-1,258,243
Closed -$8.62M
CMPX icon
7
Compass Therapeutics
CMPX
$373M
– –
-1,246,977
Closed -$2.46M
PHVS icon
8
Pharvaris
PHVS
$2.39B
– –
-33,142
Closed -$692K

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
ACH
Axis Capital Holdings Pembroke, Bermuda $270M AUM 16.26% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return

Foresite Capital Management V's Q4 2023 Portfolio in Review

As of Q4 2023, Foresite Capital Management V held 8 positions worth $73.4M, up 17% from $62.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V withdrew a net $10.8M in Q4 2023, closing 3 positions. Its most notable exit was Aclaris Therapeutics, an estimated $8.62M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management V opened a new position in 23andMe Holding Co worth $212K.

  • Foresite Capital Management V's largest Q4 2023 buy was 23andMe Holding Co: 11,610 shares worth $212K.
  • Foresite Capital Management V added most to Hims & Hers Health in Q4 2023, an estimated $739K increase.
  • Foresite Capital Management V fully exited Aclaris Therapeutics in Q4 2023, selling an estimated $8.62M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $73.4M portfolio in Q4 2023.
  • Foresite Capital Management V opened 1 new position and closed 3 in Q4 2023.
  • Foresite Capital Management V's portfolio value rose 17% quarter-over-quarter to $73.4M.

Based on Foresite Capital Management V's 13F filing for Q4 2023, filed 13 Feb 2024.